Yanhong Deng

9.7k total citations · 1 hit paper
284 papers, 5.2k citations indexed

About

Yanhong Deng is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yanhong Deng has authored 284 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 145 papers in Oncology, 76 papers in Surgery and 70 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yanhong Deng's work include Colorectal Cancer Treatments and Studies (71 papers), Colorectal Cancer Surgical Treatments (46 papers) and Colorectal and Anal Carcinomas (42 papers). Yanhong Deng is often cited by papers focused on Colorectal Cancer Treatments and Studies (71 papers), Colorectal Cancer Surgical Treatments (46 papers) and Colorectal and Anal Carcinomas (42 papers). Yanhong Deng collaborates with scholars based in China, United States and Canada. Yanhong Deng's co-authors include Maria Ciarleglio, Jianwei Zhang, Jianping Wang, Liang Kang, Yue Cai, Loren Laine, Hui Wang, Lei Wang, Jianping Wang and Xiaopan Yao and has published in prestigious journals such as Nature, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yanhong Deng

264 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA

2018 317 citations Sarah B. Goldberg, Azeet Narayan et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Yanhong Deng

Since Specialization

Citations

This map shows the geographic impact of Yanhong Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanhong Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanhong Deng more than expected).

Fields of papers citing papers by Yanhong Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanhong Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanhong Deng. The network helps show where Yanhong Deng may publish in the future.

Co-authorship network of co-authors of Yanhong Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Yanhong Deng. A scholar is included among the top collaborators of Yanhong Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanhong Deng. Yanhong Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predictors of Late Graft Failure in Hematopoietic Stem Cell Transplantation (HCT) for Sickle Cell Disease Character Limitpredictors of Late Graft Failure in Hematopoietic Stem Cell Transplantation (HCT) for Sickle Cell Disease 2025 ·Transplantation and Cellular Therapy ·(unknown), (unknown), Yanhong Deng, (unknown), (unknown), Lakshmanan Krishnamurti	1
2	Hepatotoxicity induced by polylactic acid microplastics: The mediating role of gut microbiota and uric acid metabolism 2025 ·Journal of Advanced Research ·Yanhong Deng, Zhiming Li, Yuji Huang, Yizhou Zhong, (unknown), Xiaohong Chen, (unknown), (unknown), Yujie Feng, Ruobing Bai, (unknown), Hongyi Xian, (unknown), Da Chen, Boxuan Liang, Zhenlie Huang	1
3	Combining Circulating Tumour DNA with Clinical Pathological Risk Factors for Developing Peritoneal Metastasis Prediction Model in Patients with Colorectal Cancer 2025 ·British Journal of Hospital Medicine ·(unknown), Huabin Hu, (unknown), Xiaoyu Xie, Yanhong Deng	1
4	Human umbilical cord mesenchymal stem cells mitigate A1 astrocyte neuroinflammation induced by 1,2-dichloroethane via ERBB pathway inhibition 2024 ·Ecotoxicology and Environmental Safety ·Jiaxin Du, Yizhou Zhong, (unknown), (unknown), Rongyi Ye, Yuji Huang, Zhiming Li, Boxuan Liang, Hongyi Xian, Yanhong Deng, (unknown), Xiaohong Chen, (unknown), Xiaoxuan Yu, Banghua Wu, Xingfen Yang, Zhenlie Huang	1
5	Gastrointestinal Incomplete Degradation Exacerbates Neurotoxic Effects of PLA Microplastics via Oligomer Nanoplastics Formation 2024 ·Advanced Science ·Boxuan Liang, Yanhong Deng, Yizhou Zhong, Xiaohong Chen, Yuji Huang, Zhiming Li, (unknown), (unknown), Jiaxin Du, Rongyi Ye, Hongyi Xian, Yujie Feng, Ruobing Bai, (unknown), Xingfen Yang, Zhenlie Huang	24
6	Predictors of Graft Failure Beyond 24 Months Following Hematopoietic Stem Cell Transplantation for Sickle Cell Disease 2024 ·Blood ·(unknown), (unknown), (unknown), (unknown), Yanhong Deng, Lakshmanan Krishnamurti	0
7	Circulating Tumor DNA Dynamics Fail to Predict Efficacy of Poly(ADP-ribose) Polymerase/VEGFR Inhibition in Patients With Heavily Pretreated Advanced Solid Tumors 2024 ·JCO Precision Oncology ·(unknown), Azeet Narayan, (unknown), J. M. Wolfe, Dennis Vu, (unknown), (unknown), S. Percy Ivy, Joseph P. Eder, Yanhong Deng, Patricia LoRusso, Joseph W. Kim, Abhijit A. Patel	0
8	CT-based deep learning model for the prediction of DNA mismatch repair deficient colorectal cancer: a diagnostic study 2023 ·Journal of Translational Medicine ·Wuteng Cao, Huabin Hu, (unknown), Qiyuan Qin, (unknown), Jiao Li, (unknown), Junhong Chen, Xinhua Wang, Yanhong Deng	11
9	Biomarkers of Pathologic Complete Response to Neoadjuvant Immunotherapy in Mismatch Repair–Deficient Colorectal Cancer 2023 ·Clinical Cancer Research ·Jianxia Li, Huabin Hu, Ge Qin, (unknown), Xianrui Wu, (unknown), Jianwei Zhang, (unknown), Zehua Wu, (unknown), (unknown), Longlong Gong, Zhi Xie, Yanhong Deng	16
10	Clinical Benefit of Avapritinib in KIT- Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007–001 Studies 2023 ·Clinical Cancer Research ·Michael C. Heinrich, (unknown), Robin L. Jones, Suzanne George, César Serrano, Yanhong Deng, Sebastian Bauer, Shirong Cai, (unknown), (unknown), (unknown), Zhichao Zheng, (unknown), Yuehong Cui, Hui Cao, Meining Wang, (unknown), (unknown), Jian Li, Lin Shen	4
11	Efficacy and Safety of Ripretinib in Chinese Patients with Advanced Gastrointestinal Stromal Tumors as a Fourth- or Later-Line Therapy: A Multicenter, Single-Arm, Open-Label Phase II Study 2022 ·Clinical Cancer Research ·Jian Li, Shirong Cai, Yongjian Zhou, (unknown), Ye Zhou, Hui Cao, Xin Wu, Yanhong Deng, Zhao Huang, Juan Dong, (unknown)	12
12	Identification of immune cell infiltration landscape for predicting prognosis of colorectal cancer 2022 ·Gastroenterology report ·Xueqian Wu, Jianxia Li, Yuanzhe Zhang, Yi Cheng, Zehua Wu, (unknown), Yanhong Deng	8
13	Phase 2 study of tislelizumab monotherapy in previously treated, locally advanced, unresectable or metastatic microsatellite instability-high/mismatch repair-deficient solid tumors: Gynecological cancer subgroup (127) 2022 ·Gynecologic Oncology ·Dong Wang, (unknown), Aimin Zang, Jing Wang, (unknown), Lin Shen, Jian Li, (unknown), Tianshu Liu, Yanhong Deng, Yaling Xu, (unknown), (unknown), (unknown)	0
14	Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as First-line Therapy for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma 2021 ·Clinical Cancer Research ·Zhi Peng, Jia Wei, Wang Feng, Jieer Ying, Yanhong Deng, Kangsheng Gu, Ying Cheng, Xianglin Yuan, Juxiang Xiao, (unknown), Linna Wang, (unknown), Yanqiao Zhang, Lin Shen	75
15	Direct observation in a large-scale randomized trial of parent training in children with autism spectrum disorder and disruptive behavior 2021 ·Research in autism spectrum disorders ·Naomi B. Swiezy, (unknown), (unknown), Karen Bearss, Luc Lecavalier, (unknown), (unknown), Yanhong Deng, (unknown), James Dziura, (unknown), Lawrence David Scahill	4
16	Increased branched‐chain amino acids at baseline and hours before a spontaneous seizure in the human epileptic brain 2021 ·Epilepsia ·(unknown), Eyiyemisi C. Damisah, Shaun E. Gruenbaum, Roni Dhaher, Yanhong Deng, (unknown), Hitten P. Zaveri, Dennis D. Spencer, Tore Eid	6
17	Rapid increase in hybrid surgery for the treatment of peripheral artery disease in the Vascular Quality Initiative database 2020 ·Journal of Vascular Surgery ·Arash Fereydooni, Bin Zhou, (unknown), Yanhong Deng, Alan Dardik, Cassius Iyad Ochoa Chaar	11
18	Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo‐coagulable and Hyper‐coagulable Features 2020 ·Hepatology ·Alberto Zanetto, Henry M. Rinder, Elena Campello, Graziella Saggiorato, Yanhong Deng, Maria Ciarleglio, F. Perry Wilson, Marco Senzolo, Sabrina Gavasso, Cristiana Bulato, Paolo Simioni, Guadalupe García‐Tsao	62
19	Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA breakdown → 2018 ·Clinical Cancer Research ·Sarah B. Goldberg, Azeet Narayan, Adam J. Kole, Roy H. Decker, Jimmitti Teysir, Nicholas Carriero, Angela Lee, Roxanne Nemati, Sameer K. Nath, Shrikant Mane, Yanhong Deng, Nitin Sukumar, Daniel Zelterman, Daniel J. Boffa, Katerina Politi, Scott Gettinger, Lynn D. Wilson, Roy S. Herbst, Abhijit A. Patel	317
20	Circadian Clock Gene CRY2 Degradation Is Involved in Chemoresistance of Colorectal Cancer 2015 ·Molecular Cancer Therapeutics ·Lekun Fang, Zihuan Yang, (unknown), Jung-Yu Tung, Chwan‐Deng Hsiao, Lei Wang, Yanhong Deng, (unknown), Jianping Wang, Mong‐Hong Lee	65

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact